Log in
Enquire now

List of AGENNIX, INC. patents

List of AGENNIX, INC. patents
List of Rhythmia Medical patents
List of BioLamina AB patents
List of Cellecta patents
Peer-to-peer lending venture capital investors
List of emobility service patents
Patents where
Current Assignee
Name
is
AGENNIX, INC.AGENNIX, INC.
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 7262279 Lactoferrin in the treatment of diabetes mellitus

Patent 7262279 was granted and assigned to AGENNIX, INC. on August, 2007 by the United States Patent and Trademark Office.

AGENNIX, INC.
AGENNIX, INC.
United States Patent and Trademark Office
United States Patent and Trademark Office
7262279
August 28, 2007
‌
US Patent 7238661 Oral lactoferrin in the treatment of respiratory disorders

Patent 7238661 was granted and assigned to AGENNIX, INC. on July, 2007 by the United States Patent and Trademark Office.

AGENNIX, INC.
AGENNIX, INC.
United States Patent and Trademark Office
United States Patent and Trademark Office
7238661
July 3, 2007
‌
US Patent 7420033 Composition of lactoferrin related peptides and uses thereof

Patent 7420033 was granted and assigned to AGENNIX, INC. on September, 2008 by the United States Patent and Trademark Office.

AGENNIX, INC.
AGENNIX, INC.
United States Patent and Trademark Office
United States Patent and Trademark Office
7420033
September 2, 2008
‌
US Patent 7524814 Lactoferrin compositions and methods of wound treatment

Patent 7524814 was granted and assigned to AGENNIX, INC. on April, 2009 by the United States Patent and Trademark Office.

AGENNIX, INC.
AGENNIX, INC.
United States Patent and Trademark Office
United States Patent and Trademark Office
7524814
April 28, 2009
‌
US Patent 7183381 Composition of lactoferrin related peptides and uses thereof

Patent 7183381 was granted and assigned to AGENNIX, INC. on February, 2007 by the United States Patent and Trademark Office.

AGENNIX, INC.
AGENNIX, INC.
United States Patent and Trademark Office
United States Patent and Trademark Office
7183381
February 27, 2007
‌
US Patent 7638487 Lactoferrin in the reduction of pain

Patent 7638487 was granted and assigned to AGENNIX, INC. on December, 2009 by the United States Patent and Trademark Office.

AGENNIX, INC.
AGENNIX, INC.
United States Patent and Trademark Office
United States Patent and Trademark Office
7638487
December 29, 2009
‌
US Patent 7244706 Antimicrobial/endotoxin neutralizing polypeptide

Patent 7244706 was granted and assigned to AGENNIX, INC. on July, 2007 by the United States Patent and Trademark Office.

AGENNIX, INC.
AGENNIX, INC.
United States Patent and Trademark Office
United States Patent and Trademark Office
7244706
July 17, 2007
‌
US Patent 7592306 Lactoferrin as an agent in the prevention of organ transplant rejection and graft-versus-host-disease

Patent 7592306 was granted and assigned to AGENNIX, INC. on September, 2009 by the United States Patent and Trademark Office.

AGENNIX, INC.
AGENNIX, INC.
United States Patent and Trademark Office
United States Patent and Trademark Office
7592306
September 22, 2009
‌
US Patent 7323443 Lactoferrin in the reduction of pain

Patent 7323443 was granted and assigned to AGENNIX, INC. on January, 2008 by the United States Patent and Trademark Office.

AGENNIX, INC.
AGENNIX, INC.
United States Patent and Trademark Office
United States Patent and Trademark Office
7323443
January 29, 2008
‌
US Patent 7034126 Lactoferrin in the treatment of diabetes mellitus

Patent 7034126 was granted and assigned to AGENNIX, INC. on April, 2006 by the United States Patent and Trademark Office.

AGENNIX, INC.
AGENNIX, INC.
United States Patent and Trademark Office
United States Patent and Trademark Office
7034126
April 25, 2006
10 results
0 selected
10 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us